Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

A Biologically Based Approach to Prevent Obesity in Older Adolescents and Young Adults

Award Number: R01DK142604
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/06/2026
PERIOD OF PERFORMANCE END DATE: 02/28/2031

Group Awards By:

View Award Description

A Biologically Based Approach to Prevent Obesity in Older Adolescents and Young Adults - Abstract Once obesity develops and becomes entrenched, achieving sustained weight loss is extremely difficult. Thus, preventing the accumulation of excess adiposity in high-risk individuals is the ideal course of action. Adolescents/young adults (AYAs) are high-risk individuals, as this is a life stage characterized by susceptibility for accelerated weight gain. However, most obesity prevention interventions targeting AYAs have reported null findings or modest effects. It is possible that failure to address the underlying physiology of the energy regulatory system is at least partly responsible for the underwhelming results. Previous obesity prevention interventions in AYAs have almost entirely focused on modifying individual behaviors and/or external environmental conditions and have not addressed the biological pathways driving energy regulation. Effectively targeting the underlying physiological processes promoting body fat storage, such as with pharmacotherapy, may be an essential component of successful obesity prevention for some individuals. When used in combination with lifestyle-based weight gain prevention counseling, low-dose preventative pharmacotherapy has the potential to halt or slow unhealthy weight gain by targeting key mechanisms in the energy regulatory system. Phentermine/topiramate is among the most cost-effective obesity medications approved for adolescents and adults. Its mechanisms of action may be ideal for impeding weight gain and ultimately preventing the onset of obesity because they are multifactorial and involve reducing appetite, enhancing satiety, and potentially increasing energy expenditure. Flexible dosing with phentermine/topiramate provides the option to introduce preventative pharmacotherapy at low levels of exposure yet allows for dose escalation if weight gain were to ensue. In the proposed clinical trial, we plan to diverge significantly from historical obesity prevention approaches by pairing lifestyle-based weight gain prevention coaching with low-dose preventative pharmacotherapy to target the underlying biological processes implicated in weight gain. We will target AYAs (18 to <25 years old) at risk of developing obesity: defined as those with a BMI between 25-29.9 kg/m2 (overweight classification) and a family history of obesity (one biological parent with severe obesity and/or two biological parents with obesity). We will randomize 140 of these individuals (1:1) to phentermine/topiramate or placebo with both groups additionally receiving lifestyle- based weight gain prevention coaching. Over a period of two years, we will: 1) compare changes between groups in BMI trajectories as well as incidence of obesity and regression to normal weight; 2) identify mechanisms of action related to appetite, satiety, cravings and energy expenditure as well as determine if there are differences between groups in diet quality and disordered eating behaviors; and 3) investigate changes in visceral adipose tissue and its relation to cardiometabolic risk. In this study we will take a fundamentally different approach to the science of obesity prevention by targeting the underlying biological processes driving unhealthy weight gain in AYAs, a group that has been underrepresented in medication trials.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $759,944 )
2026	2026	REGENTS OF THE UNIVERSITY OF MINNESOTA	2221 UNIVERSITY AVE SE STE 100	MINNEAPOLIS	MN	55414	HENNEPIN	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	3/5/2026	NEW	$759,944
														Subtotal = $759,944

Grand Total All Awards = $759,944

Top

All Categories

About

Search

Reports

Data Submission

Award Information

A Biologically Based Approach to Prevent Obesity in Older Adolescents and Young Adults

Award Number: R01DK142604

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/06/2026

PERIOD OF PERFORMANCE END DATE: 02/28/2031

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer